Clinical Trials on Breast Asymmetry in Hong Kong
Total 258 results
-
Hong Kong Baptist UniversityActive, not recruiting
-
Organisation for Oncology and Translational ResearchCompleted
-
Chinese University of Hong KongPrincess Margaret Hospital, Hong KongRecruiting
-
The University of Hong KongActive, not recruitingBreast Cancer | Sentinel Lymph NodeHong Kong
-
The University of Hong KongRecruitingFatigue | Exercise | Cancer, Breast | AcupressureHong Kong
-
The University of Hong KongEndomagnetics Ltd.RecruitingBreast Neoplasm | Chemotherapy EffectHong Kong
-
Chinese University of Hong KongUnknown
-
CCTUCompleted
-
The Hong Kong Polytechnic UniversityQueen Elizabeth Hospital, Hong KongCompleted
-
Chinese University of Hong KongActive, not recruiting
-
The Hong Kong Polytechnic UniversityRecruitingParents | Breast Feeding, ExclusiveHong Kong
-
The University of Hong KongFood and Health Bureau, Hong Kong GovernmentActive, not recruiting
-
The University of Hong KongCompletedChemotherapy | Breast Cancer Female | Insomnia, SecondaryHong Kong
-
The University of Hong KongCompletedChemotherapy | Breast Cancer Female | Insomnia, SecondaryHong Kong
-
Organisation for Oncology and Translational ResearchUnknownLetrozole and CDK 4/6 Inhibitor for ER Positive, HER2 Negative Breast Cancer in Postmenopausal WomenER Positive, HER2 Negative Breast CancerChina
-
Organisation for Oncology and Translational ResearchUnknownHormone Receptor Positive Malignant Neoplasm of BreastChina
-
Chinese University of Hong KongIBM China/Hong Kong LimitedWithdrawn
-
National Cancer Institute (NCI)Chinese University of Hong KongCompleted
-
Organisation for Oncology and Translational ResearchUnknown
-
The University of Hong KongCompleted
-
The Queen Elizabeth HospitalCompleted
-
Chinese University of Hong KongDepartment of Electronic and computer engineering, HKUST; Department of clinical... and other collaboratorsRecruitingBreast CancerHong Kong
-
Organisation for Oncology and Translational ResearchUnknown
-
The Hong Kong Polytechnic UniversityCompletedBreast Neoplasms | Colorectal NeoplasmsChina
-
The University of Hong KongChinese University of Hong KongCompletedBreast Cancer | Mild Cognitive Impairment | Drug-Related Side Effects and Adverse Reactions | Chemo-brainChina, Hong Kong
-
Chinese University of Hong KongRecruitingObesity | Breast Cancer | Colorectal Cancer | Prostate CancerHong Kong
-
Chinese University of Hong KongEnrolling by invitation
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastHong Kong, China
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
PfizerTerminatedBreast CancerUnited States, Belgium, Hungary, China, Hong Kong, Poland, Singapore
-
PfizerTerminatedAdvanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)United States, Spain, Hong Kong, Belgium, Australia, France
-
Puma Biotechnology, Inc.CompletedBreast CancerSpain, United Kingdom, France, United States, Denmark, Hong Kong
-
Uppsala UniversityBaylor College of Medicine; Sahlgrenska University Hospital, Sweden; University... and other collaboratorsRecruitingBreast Cancer | Breast Neoplasms | Sentinel Lymph Node | DCISUnited States, Sweden, Hong Kong
-
Zai Lab (Shanghai) Co., Ltd.TerminatedGastric Cancer | Triple Negative Breast Cancer | Endometrial Carcinoma | Biliary Tract CarcinomaChina
-
Novartis PharmaceuticalsCompletedPre-menopausal Breast Cancer | PI3K Pathway InhibitionTaiwan, Hong Kong, Thailand, Korea, Republic of
-
ASLAN PharmaceuticalsCompletedMetastatic Breast CancerAustralia, Hong Kong, Korea, Republic of, New Zealand, Philippines, Singapore, Taiwan
-
Kyoto Breast Cancer Research NetworkPfizerCompletedHormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer FemaleTaiwan, Japan, Korea, Republic of, Australia, Hong Kong
-
Novartis PharmaceuticalsTerminatedTriple Negative Breast Cancer (TNBC)Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
-
Boehringer IngelheimCompletedBreast NeoplasmsHong Kong, Taiwan, United Kingdom, Russian Federation, India, Poland
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Spain, Belgium, Hong Kong, France
-
Novartis PharmaceuticalsActive, not recruitingMelanoma | Carcinoma, Non-Small-Cell Lung | Nasopharyngeal Carcinoma | Triple Negative Breast Cancer | Microsatellite Stable Colorectal CancerUnited States, Taiwan, Spain, Germany, Japan, Hong Kong
-
Boehringer IngelheimCompletedBreast NeoplasmsUnited States, Australia, Hong Kong, Korea, Republic of, Thailand, Tunisia, United Kingdom
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive, HER2-negative, Advanced Breast CancerJapan, Hong Kong, Singapore
-
PfizerCompletedBreast Neoplasms | Neoplasm MetastasisUnited States, Ukraine, Russian Federation, Hong Kong, France, Australia, Poland, Malta
-
Spectrum Pharmaceuticals, IncTerminatedBreast Cancer | Colorectal Cancer | Solid Tumor | Glioblastome MultiformeUnited States
-
Puma Biotechnology, Inc.CompletedBreast CancerUnited States, Spain, China, Hungary, Singapore, Australia, Russian Federation, Hong Kong, Brazil, Croatia, Korea, Republic of
-
QT Ultrasound LLCCompleted
-
Rutgers, The State University of New JerseyActive, not recruitingBreast Cancer, Early-OnsetUnited States
-
Monash UniversityRoyal Perth HospitalRecruitingBreast Cancer | Mastectomy | Breast Cancer Female | Breast Conserving SurgeryAustralia, New Zealand, Hong Kong
-
Puma Biotechnology, Inc.CompletedBreast Neoplasms | Advanced Breast Cancer | Advanced Malignant Solid TumorsUnited States, Belgium, China, Hong Kong, Canada, Korea, Republic of, India, Poland, Ukraine